China Medical & HealthCare Group ( (HK:0383) ) just unveiled an announcement.
TianAn Medicare Limited has issued a positive profit alert, indicating an expected increase in profits for the year ending December 31, 2024, with estimates ranging from HK$19.9 million to HK$29.9 million, compared to HK$14.7 million in 2023. This anticipated growth is attributed to increased revenue from its Healthcare Division and reduced finance costs in China, although partially offset by losses in investment properties, foreign exchange, and the closure of a polyclinic in Nanjing.
More about China Medical & HealthCare Group
China Medical & HealthCare Group operates in the healthcare industry, focusing on providing medical services and healthcare solutions. The company is involved in various healthcare operations, including medical insurance settlements and polyclinic services, primarily within the People’s Republic of China.
Learn more about 0383 stock on TipRanks’ Stock Analysis page.